Coloplast ASCLPBF 72 Net Margin % is -13.71% as of Mar. 2026. GuruFocus rates CLPBF with a GF Score™ of 72/100 and a GF Value™ of $126.91 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Coloplast AS ranks better than 66.22% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Coloplast AS's Net Income for the
three
months ended in Mar. 2026 was $-150 Mil. Coloplast AS's Revenue for the
three
months ended in Mar. 2026 was $1,096 Mil. Therefore, Coloplast AS's net margin for the quarter that ended in Mar. 2026 was -13.71%.
The historical rank and industry rank for Coloplast AS's Net Margin % or its related term are showing as below:
CLPBF'
s Net Margin % Range Over the Past 10 Years
Min: 7.51 Med: 21.5 Max: 24.84
Current: 7.51
CLPBF's Net Margin % is ranked better than 66.22% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs CLPBF: 7.51
Coloplast AS (OTCPK:CLPBF) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Coloplast AS Net Margin % Related Terms
Coloplast AS Net Margin % Historical Data
* Premium members only.
The historical data trend for Coloplast AS's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Coloplast AS's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Coloplast AS Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Net Margin % distribution charts can be found below:
* The bar in red indicates where Coloplast AS's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Coloplast AS (CLPBF) has a Net Margin % of -13.71% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Coloplast AS and its competitors. Over the past decade, Coloplast AS's Net Margin % has ranged from 7.51 to 24.84. According to the industry distribution chart, Coloplast AS ranks #276 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 33.8%.
Is Coloplast AS's Net Margin % too high?
Coloplast AS's current Net Margin % is -13.71%. Over the past 10 years, this metric has ranged from a low of 7.51 to a high of 24.84. Based on the distribution chart, Coloplast AS ranks #276 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Coloplast AS has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Coloplast AS's Net Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Coloplast AS ranks #276 out of 817 companies for Net Margin %. This puts Coloplast AS in the upper half of its industry. The industry median Net Margin % is 2.07. Historically, Coloplast AS's own Net Margin % has ranged from 7.51 to 24.84 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Coloplast AS and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Coloplast AS's current Net Margin % is -13.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coloplast AS stock overvalued right now?
Based on GuruFocus' analysis, Coloplast AS (CLPBF) is currently considered Significantly Undervalued. The stock's GF Value™ is $126.91, compared to a current price of $57.41 — trading 54.8% below its estimated fair value. The current Net Margin % is -13.71%. Coloplast AS's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Coloplast AS (CLPBF), the current Net Margin % is -13.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Coloplast AS (CLPBF) Overvalued in 2026?
Based on GuruFocus' analysis, Coloplast AS stock appears to be undervalued.
The current stock price of $57.41 is trading 54.8% below its estimated GF Value™ of $126.91.
GuruFocus considers Coloplast AS to be Significantly Undervalued.
Key valuation signals for CLPBF:
Net Margin %: -13.71%
GF Value™: $126.91 vs. price of $57.41 (54.8% below fair value)
No single metric tells the full story. See the CLPBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
72GF Score
Get the complete analysis for CLPBF
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLPBF has been successfully added to your 
